Literature DB >> 9398651

CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells.

R F Thorne1, C J Meldrum, S J Harris, D J Dorahy, D R Shafren, M C Berndt, G F Burns, P G Gibson.   

Abstract

CD36 is a transmembrane glycoprotein expressed on the surface of a number of cell types. The analysis of CD36 from platelets using immunoblotting, gel filtration, and native PAGE indicated the presence of high molecular complexes exceeding the Mr of monomeric CD36. Experiments using transfected COS-7 cells revealed these complexes were homodimers and -multimers of CD36. The multimers could be dissociated by treatment with a reducing agent, indicating they were formed by intermolecular cysteine-bridging. Mutagenesis of the cDNA for CD36 implicated the cysteines in the extracellular domain of the molecule. The potential physiological roles of CD36 multimerisation are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398651     DOI: 10.1006/bbrc.1997.7755

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Extracellular disulfide bonds support scavenger receptor class B type I-mediated cholesterol transport.

Authors:  Gabriella A Papale; Paul J Hanson; Daisy Sahoo
Journal:  Biochemistry       Date:  2011-06-24       Impact factor: 3.162

Review 2.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

3.  Critical residues and motifs for homodimerization of the first transmembrane domain of the plasma membrane glycoprotein CD36.

Authors:  Peng Wei; Fu-de Sun; Li-Min Zuo; Jing Qu; Peng Chen; Li-da Xu; Shi-Zhong Luo
Journal:  J Biol Chem       Date:  2017-03-23       Impact factor: 5.157

4.  Dual processing of FAT1 cadherin protein by human melanoma cells generates distinct protein products.

Authors:  Elham Sadeqzadeh; Charles E de Bock; Xu Dong Zhang; Kristy L Shipman; Naomi M Scott; Chaojun Song; Trina Yeadon; Camila S Oliveira; Boquan Jin; Peter Hersey; Andrew W Boyd; Gordon F Burns; Rick F Thorne
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

5.  Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity.

Authors:  Thomas J F Nieland; Jared T Shaw; Firoz A Jaipuri; Jay L Duffner; Angela N Koehler; Sotirios Banakos; Vassilis I Zannis; Tomas Kirchhausen; Monty Krieger
Journal:  Biochemistry       Date:  2007-12-08       Impact factor: 3.162

6.  Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins.

Authors:  Catherine A Martin; Emma Longman; Carol Wooding; Sarah J Hoosdally; Saira Ali; Timothy J Aitman; Daniel A P Gutmann; Paul S Freemont; Bernadette Byrne; Kenneth J Linton
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

Review 7.  Endothelial Cell Receptors in Tissue Lipid Uptake and Metabolism.

Authors:  Nada A Abumrad; Ainara G Cabodevilla; Dmitri Samovski; Terri Pietka; Debapriya Basu; Ira J Goldberg
Journal:  Circ Res       Date:  2021-02-04       Impact factor: 17.367

8.  Identification of a suppressor of the Dictyostelium profilin-minus phenotype as a CD36/LIMP-II homologue.

Authors:  I Karakesisoglou; K P Janssen; L Eichinger; A A Noegel; M Schleicher
Journal:  J Cell Biol       Date:  1999-04-05       Impact factor: 10.539

9.  CD36 is a co-receptor for hepatitis C virus E1 protein attachment.

Authors:  Jun-Jun Cheng; Jian-Rui Li; Meng-Hao Huang; Lin-Lin Ma; Zhou-Yi Wu; Chen-Chen Jiang; Wen-Jing Li; Yu-Huan Li; Yan-Xing Han; Hu Li; Jin-Hua Chen; Yan-Xiang Wang; Dan-Qing Song; Zong-Gen Peng; Jian-Dong Jiang
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

10.  The origin of circulating CD36 in type 2 diabetes.

Authors:  M J Alkhatatbeh; A K Enjeti; S Acharya; R F Thorne; L F Lincz
Journal:  Nutr Diabetes       Date:  2013-02-04       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.